Amyotrophic Lateral Sclerosis (ALS) otherwise known as Lou Gehrig’s Disease or Motor Neuron Disease (MND) is a fatal, rapidly progressive neuromuscular disease that affects approximately 3,000 Canadians and more than 350 Manitobans.

More about ALS Next

Our website is intended to offer comprehensive information about ALS/MND, about the ALS Society of Manitoba, information for people with ALS/MND and their caregivers, health care professionals, donors, media, and the general public. It is our hope that this site be a source of meaningful information, a site that connects people both from within and outside the ALS/MND community and a site that users visit regularly. Be sure to let us know if there is a way to improve this site, and make it more user friendly. We want to know! Call us at: (204) 831-1510 or e-mail: HOPE@alsmb.ca

 Recent Webinars

Targeting a Specific Toxic Protein as a Therapy for ALS. Presented by Dr. Jiming Kong, University of Manitoba. What if we could deliver treatments through the bloodstream that would assist the motor neuron in getting rid of a toxic protein known to cause ALS? During this webinar, Dr. Kong presented his work that uses mice to test this innovative research in the lab.

More PAST WEBINARS

Recent News

New Walk Locations for 2019! We are expanding our Manitoba Walk for ALS locations in 2019. We are looking for volunteers who are energized and can help as Walk Coordinators for Brandon and Dauphin. If you are interested or need more information, call (204) 831-1510 or email HOPE@alsmb.ca by December 14, 2018. Together we can Walk to End ALS!

Thanks to donor generosity ALS Canada invests $1 million in innovative Canadian ALS research to provide a greater understanding of ALS. November 15, 2018. The ALS Canada Research Program awards eight new project grants in the pursuit of new therapy targets. Read more.

Grant to Fund Research Into New ALS Treatment.  October 22, 2018. Dr. Renée Douville, Associate Professor, The University of Winnipeg, has been awarded a three-year, US$300,000 grant from The ALS Association (U.S.) to study the role that viruses in the human genome play in ALS and examine the use of market-available medication in treating symptoms of the disease. Read more.

Health Canada approves new drug to treat patients with Amyotrophic Lateral Sclerosis (ALS). October 4, 2018. Read more.

ALS Research Update (ALS Canada). October, 2018. Learn about the most recent research discoveries on ALS/MND.

More RECENT NEWS

2018 Manitoba Caregiver Recognition Day

April 3, 2018. On the first Tuesday of April, Manitobans come together to recognize family members, friends, neighbours, and other significant people who take on a caring role to support someone with a diminishing physical ability, a debilitating cognitive condition or a chronic life-limiting illness. Known as Manitoba Caregiver Recognition Day, this special day encourages to pay tribute and recognize the valuable contribution of family caregivers to our lives and our community as a whole. Click here to read more.

CONNECT with us

Sign up for our NEWSLETTER and get connected to the ALS community with the latest news about research, events, programs, and services delivered right to your inbox.

By submitting this form, you are granting ALS Society of Manitoba permission to email you. You may unsubscribe anytime via the link found at the bottom of every email.

Watch our video

Patients diagnosed with ALS, as everybody else, deserve fulfilling lives and need our support. Join the ALSMB community and help us to bring HOPE to Manitobans affected by ALS.

Your donations allow the ALS Society of Manitoba to lend equipment and learning resources, and to offer such services as support groups, client services coordination, caregiver days, and more.

Registered Charity Number 120654421 RR0001

Donate now Next

Publication Archive

Call us at 204-831-1510 or email HOPE@alsmb.ca